drugset / Trial / NCT01422382

Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin

NCT01422382

Phase 4 Completed 28 enrolled Kowa Research Institute, Inc.
Non-randomizedSingle-groupOpen-label

Summary

This is a Phase 4, single-center, open-label, fixed-sequence, multiple-dose, 2-way drug-drug interaction study.

Timeline

Start
2011-05
Primary completion
2011-06
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule 240 mg
Subject Pitavastatin Small molecule 4 mg

Indications

No indication recorded.